Receptor-mediated targeting of cathepsins in professional antigen presenting cells

Angewandte Chemie - International Edition

Volumn 48, Issue 9, 2009, Pages 1629-1632

  Hillaert, Ulrik ^a   Verdoes, Martijn ^a   Florea, Bogdan I ^a   Saragliadis, Anastasios ^a   Habets, Kim L L ^b   Kuiper, Johan ^b   Van Calenbergh, Serge ^d   Ossendorp, Ferry ^e   Van Der Marel, Gijsbert A ^a   Driessen, Christoph ^c   Overkleeft, Hermen S ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c University of Ghent ^*  (Switzerland)

^d GHENT UNIVERSITY   (Belgium)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cycloaddition; Enzyme inhibitors; Hydrolases; Mannoside; Proteomics

Indexed keywords

ANTIGENS; CHEMICAL REACTIONS; MOLECULAR BIOLOGY;

ANTIGEN PRESENTING CELLS; CHEMICAL EQUATIONS; ENZYME INHIBITORS; HYDROLASES; MANNOSIDE; MODULAR APPROACHES; PROTEOMICS;

ENZYMES;

CATHEPSIN; CELL SURFACE RECEPTOR; DCG 04; DRUG DERIVATIVE; LECTIN; LEUCINE; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; CHEMISTRY; IMMUNOLOGY; METABOLISM; RAT; SYNTHESIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; CATHEPSINS; CELLS, CULTURED; LECTINS, C-TYPE; LEUCINE; MANNOSE-BINDING LECTINS; RATS; RECEPTORS, CELL SURFACE;

EID: 60749121561     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200805529     Document Type: Article

References (22)

1. a) M. Fonovic, M. Bogyo, Curr. Pharm. Des. 2007, 13, 253-261;
2. b) B. F. Cravatt, A. T. Wright, J. W. Kozarich, Annu. Rev. Biochem. 2008, 77, 383-414;
3. c) M. J. Evans, B. F. Cravatt, Chem. Rev. 2006, 106, 3279-3301.
4. D. Greenbaum, K. F. Medzihradsky, A. Burlingame, M. Bogyo, Chem. Biol. 2000, 7, 569-581.
5. A. M. Sadaghiani, S. H. L. Verhelst, M. Bogyo, Curr. Opin. Chem. Biol. 2007, 11, 20-28.
6. K. Brix, A. Dunkhorst, K. Mayer, S. Jordans, Biochimie 2008, 90, 194-207.
7. a) H. A. Chapman, Curr. Opin. Immunol. 2006, 18, 78-84;
8. b) R. J. Riese, H. A. Chapman, Curr. Opin. Immunol. 2000, 12, 107-113;
9. c) K. Honey, A. Y. Rudensky, Nat. Rev. Immunol. 2003, 5, 685-692.
10. S. Burgdorf, C. Schölz, A. Kautz, R. Tampé, C. Kurts, Nat. Immunol. 2008, 9, 558-566.
11. A. M. Lennon-Dumenil, A. H. Bakker, R. Maehr, E. Fiebiger, H. S. Overkleeft, M. Rosemblatt, H. L. Ploegh, C. Lagaudriere-Gesbert, J. Exp. Med. 2002, 196, 529-539.
12. Some examples of synthetic mannosides: a) M. A. Brimble, R. Kowalczyk, P. W. R. Harris, P. R. Dunbar, V. J. Muir, Org. Biomol. Chem. 2008, 6, 112-121;
13. b) P. Free, C. A. Hurley, T. Kageyama, B. M. Chain, A. B. Tabor, Org. Biomol. Chem. 2006, 4, 1817-1830;
14. c) E. A. L. Biessen, F. Noorman, M. E. van Teijlingen, J. Kuiper, M. Barrett-Bergshoeff, M. K. Bijsterbosch, D. C. Rijken, T. J. C. van Berkel, J. Biol. Chem. 1996, 271, 28024-28030.
15. D. Greenbaum, A. Baruch, L. Hayrapetian, Z. Darula, A. Burlingame, K. F. Medzihradsky, M. Bogyo, Mol. Cell. Proteomics 2002, 1, 60-68.
16. M. Verdoes, B. I. Florea, U. Hillaert, L. I. Willems, W. A. van der Linden, M. Sae-Heng, D. V. Filippov, A. F. Kisselev, G. A. van der Marel, H. S. Overkleeft, ChemBioChem 2008, 9, 1735-1738.
17. a) C. W. Tornøe, C. Christensen, M. Meldal, J. Org. Chem. 2002, 67, 3057-3064;
18. b) V. V. Rostovtsev, L. G. Green, V. V. Fokin, B. K. Sharpless, Angew. Chem. 2002, 114, 2708-2711;
19. Angew. Chem. Int. Ed. 2002, 41, 2596-2599;
20. c) For a comprehensive review, see: M. Meldal, C. W. Tornøe, Chem. Rev. 2008, 108, 2952-3015.
21. LC-MS (liquid chromatography mass spectroscopy) analysis after HPLC purification indicated partial hydrolysis (ca. 10%) of the ethyl ester of the epoxysuccinate moiety. Hydrolysis of epoxysuccinate esters in aqueous environment has been reported and it has been suggested that these esters serve as pro-drugs of the corresponding carboxylic acid (J. P. Meara, D. H. Rich, J. Med. Chem. 1996, 39, 3357-3366).
22. T. Keler, V. Ramakrishna, M. W. Fanger, Expert Opin. Biol. Ther. 2004, 4, 1953-1962.